Tower Research Capital (TRC)’s Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock VHAQ.U Stock Holding History

Tower Research Capital (TRC)’s Portfolio VHAQ.U Stock Details VHAQ.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-140	Closed	-$1K	–	6309
2021 Q2	$1K	Sell	140 -1,039	-88%	-$10.8K	﹤0.01%	5291
2021 Q1	$12K	Buy	1,179 +179	+18%	+$1.89K	﹤0.01%	4289
2020 Q4	$10K	Buy	+1,000	New	+$10.3K	﹤0.01%	4337

Other funds holding VHAQ.U

LCM

Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SAM

Seelaus Asset Management Chatham, New Jersey $142M AUM 48.58% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Tower Research Capital (TRC)'s VHAQ.U Position: Q3 2021 in Review

Tower Research Capital (TRC) sold out of Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock (VHAQ.U) in Q3 2021, closing a stake of 140 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in VHAQ.U in Q4 2020 and held it in 3 quarters. The position peaked at $12K in Q1 2021. 11 funds tracked by Wall St. Rank hold VHAQ.U as of Q3 2021.

Tower Research Capital (TRC) reported no remaining Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock position as of Q3 2021 after selling out during the quarter.
Tower Research Capital (TRC) sold 140 Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock shares in Q3 2021, an estimated $1K.
Tower Research Capital (TRC) first reported a position in Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock in Q4 2020 and held it in 3 quarters.
Tower Research Capital (TRC)'s Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock position peaked at $12K in Q1 2021.
11 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock as of Q3 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.